SPRY ARS Pharma: Accounting Value per Share

Graphic logo of ARS Pharmaceuticals (SPRY)

ARS Pharmaceuticals (SPRY) specializes in developing emergency therapies, where success depends on the approval of new drug delivery methods and support from insurers. This daily price chart shows the stock is currently trading at 0.13. The launch of allergy nasal sprays into global markets mitigates risks, while steady demand for current products guarantees a stable cash flow.

ARS Pharmaceuticals Inc (SPRY): Share Book Value from 04/28/2023 to 10/27/2026
Manufactured products of ARS Pharmaceuticals, Inc.

ARS Pharmaceuticals maintains a unique market niche through the development of an unrivaled nasal spray. The company's strong pricing power directly impacts its net asset value. This metric is calculated as the difference between total assets and liabilities, divided by the number of shares. It allows investors to filter out speculative noise by assessing the business's tangible assets. By analyzing the book value per share, an investor determines the intrinsic value of the security without paying a market premium.

Competitors of ARS Pharmaceuticals (SPRY)

Net Assets per Single Share Haleon Group (HLN)|Kenvue Health (KVUE) - Accounting Value of a Share|Accounting Value per Share VRNA|MENS (jyongbio.com) - Net Asset Value per Share|Net Assets per Single Share Ligand LGND|Share Book Value Amneal Pharmaceuticals, Inc.|Perrigo Company (PRGO) - Book Value per Share|Accounting Value of a Share Alvotech Biopharmaceuticals (ALVO)|Book Value per Share LQDA (Liquidia Corporation)|glpg.com - Book Value per Share|Net Assets per Single Share ANI Pharmaceuticals, Inc. (ANIP)|MNKD: Accounting Value of a Share|AMPH (Amphastar) - Net Assets per Single Share|Pacira Corp (PCRX) - Accounting Value per Share|TBPH (Theravance Biopharma) - Book Value per Share|Book Value per Share aquestive.com (AQST)|scPharmaceuticals Inc. (SCPH) - Accounting Value per Share|Accounting Value of a Share TECX (tectonictx.com)|TNXP: Net Assets per Single Share|SXTC - Net Asset Value per Share|Accounting Value per Share Eupraxia Pharma EPRX|BHST - Book Price of a Share|Book Value per Share eXoZymes EXOZ|Oramed Pharmaceuticals Inc. (ORMP) - Accounting Value of a Share|Book Value per Share ENTX (Entera Bio Ltd)|Net Asset Value per Share HYFT|ABVC BioPharma (ABVC) - Net Assets per Single Share|Accounting Value of a Share cumberlandpharma.com (CPIX)|Book Value per Share QNTM (Quantum BioPharma)|FibroGen Inc - Book Value per Share|Net Assets per Single Share Telomir Pharma (TELO)|RANI: Accounting Value of a Share|synergychc.com - Net Assets per Single Share|Net Assets per Share Rallybio|LEXX - Accounting Value per Share|Accounting Value of a Share PULM|PTHL - Net Assets per Single Share|Share Book Value aptorumgroup.com (APM)|Book Value per Share Lyra Therapeutics, Inc.|Accounting Value of a Share Impact BioMedical, Inc. IBO|TNF Pharma - Book Value per Share|YCBD: Book Value per Share|Net Assets per Single Share PainReform Limited PRFX|CYTO (Altamira Therapeutics Ltd.) - Accounting Value of a Share|Net Assets per Single Share LIPO|Accounting Value per Share optinose.com|Book Value per Share PIRS|Book Value per Share Procaps Group (PROC)|Petros - Book Value per Share|Accounting Value per Share Qilian International Corp QLI|SLRN (Acelyrin, Inc.) - Book Value per Share|tffpharma.com (TFFP) - Net Asset Value per Share